When your body has everything it needs, it can function at its highest level, and that internal health is reflected in your outward appearance
Although casein was one of the first proteins subjected to the AUC analysis as early as 1930 (Svedberg et al., 1930a
Getting regular exercise helps you keep your muscles while youre losing weight and makes your body better at using insulin
Researchers tracking peptide clinical trial news should note these ongoing studies: NAFLD/NASH Research The most significant ongoing research involves tesamorelin NAFLD (nonalcoholic fatty liver disease) studies: Rationale: Tesamorelin's documented reduction of visceral adipose tissue may benefit hepatic fat accumulation Key studies: Multiple trials have evaluated tesamorelin's effects on liver fat content in HIV and non-HIV populations Published findings (2024-2025): Studies in JAMA Internal Medicine and Hepatology have documented reductions in hepatic fat fraction Latest tesamorelin research 2025-2026: Recent studies from 2024-2026 continue to evaluate hepatic fat reduction in non-HIV NAFLD/MASH populations, with new analyses examining long-term durability of VAT reduction Cognitive Function Studies Research has explored tesamorelin's effects on cognitive function, particularly in HIV patients where cognitive impairment is common: GH/IGF-1 axis involvement in neuroprotection Studies examining memory and executive function outcomes Ongoing investigation of mechanisms beyond metabolic effects Body Composition Research As a tesamorelin growth hormone analog, research continues into body composition effects: Trunk fat reduction Lipid profile improvements Metabolic marker changes ClinicalTrials.gov Listings Researchers can search ClinicalTrials.gov for "tesamorelin" to find current and completed studies
It is a contraindication based on thyroid cancer risk
Insulin Like Growth Factor and Diabetes: Core Concepts Insulin-like growth factor 1 (IGF-1) is a peptide hormone produced mainly by the liver under growth hormone (GH) stimulation
